Compare EBS & TTGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | TTGT |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.6M | 416.4M |
| IPO Year | 2006 | 2024 |
| Metric | EBS | TTGT |
|---|---|---|
| Price | $8.24 | $3.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $10.75 |
| AVG Volume (30 Days) | ★ 728.7K | 463.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.83 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $742,900,000.00 | N/A |
| Revenue This Year | $1.29 | $4.45 |
| Revenue Next Year | N/A | $2.75 |
| P/E Ratio | $113.57 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.62 | $3.41 |
| 52 Week High | $14.06 | $9.00 |
| Indicator | EBS | TTGT |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 34.44 |
| Support Level | $7.76 | $3.52 |
| Resistance Level | $8.54 | $5.88 |
| Average True Range (ATR) | 0.46 | 0.31 |
| MACD | -0.06 | -0.12 |
| Stochastic Oscillator | 34.78 | 6.93 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.